{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:15:17Z","timestamp":1790712917136,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":2471,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1074\/jbc.m113.527754","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T01:14:01Z","timestamp":1386292441000},"page":"2826-2838","source":"Crossref","is-referenced-by-count":28,"title":["Down-modulation of SEL1L, an Unfolded Protein Response and Endoplasmic Reticulum-associated Degradation Protein, Sensitizes Glioma Stem Cells to the Cytotoxic Effect of Valproic Acid"],"prefix":"10.1016","volume":"289","author":[{"given":"Monica","family":"Cattaneo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Baronchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mellai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Caldera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Jotti","family":"Saccani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda","family":"Dalpra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Daga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"DeBlasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Biunno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.527754_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrc1799","article-title":"Epigenetic gene silencing in cancer. A mechanism for early oncogenic pathway addiction?","volume":"6","author":"Baylin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M113.527754_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3747\/co.v15i5.371","article-title":"Histone deacetylase inhibitors as novel anticancer therapeutics","volume":"15","author":"Walkinshaw","year":"2008","journal-title":"Curr. Oncol"},{"key":"10.1074\/jbc.M113.527754_bib3","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/stem.89","article-title":"DNER, an epigenetically modulated gene, regulates glioblastoma. Derived neurosphere cell differentiation and tumor propagation","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells"},{"key":"10.1074\/jbc.M113.527754_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-007-9402-7","article-title":"Valproic acid induces p21 and topoisomerase-II (\u03b1\/\u03b2) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines","volume":"85","author":"Das","year":"2007","journal-title":"J. Neurooncol"},{"key":"10.1074\/jbc.M113.527754_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10585-007-9131-5","article-title":"Histone deacetylases. Target enzymes for cancer therapy","volume":"25","author":"Mottet","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1074\/jbc.M113.527754_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-1-4020-6554-5_13","article-title":"Histone deacetylase inhibitors. Mechanisms and clinical significance in cancer. HDAC inhibitor-induced apoptosis","volume":"615","author":"Shankar","year":"2008","journal-title":"Adv. Exp. Med. Biol"},{"key":"10.1074\/jbc.M113.527754_bib7","first-page":"2437","article-title":"Influence of valproic acid on outcome of high-grade gliomas in children","volume":"28","author":"Masoudi","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1074\/jbc.M113.527754_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1158\/1078-0432.CCR-10-0738","article-title":"Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors. A children's oncology group report","volume":"17","author":"Su","year":"2011","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.M113.527754_bib9","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1582-4934.2011.01296.x","article-title":"Grand Rounds at the National Institutes of Health. HDAC inhibitors as radiation modifiers, from bench to clinic","volume":"15","author":"Shabason","year":"2011","journal-title":"J. Cell Mol. Med"},{"key":"10.1074\/jbc.M113.527754_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1620\/tjem.219.17","article-title":"Angiotensin II induces cardiomyocyte hypertrophy probably through histone deacetylases","volume":"219","author":"Lu","year":"2009","journal-title":"Tohoku J. Exp. Med"},{"key":"10.1074\/jbc.M113.527754_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1593\/neo.91422","article-title":"Activation of the unfolded protein response contributes toward the antitumor activity of vorinostat","volume":"12","author":"Kahali","year":"2010","journal-title":"Neoplasia"},{"key":"10.1074\/jbc.M113.527754_bib12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.semcdb.2007.09.003","article-title":"The endoplasmic reticulum and the unfolded protein response","volume":"18","author":"Malhotra","year":"2007","journal-title":"Semin. Cell Dev. Biol"},{"key":"10.1074\/jbc.M113.527754_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bcp.2012.09.012","article-title":"Pharmacological targeting of endoplasmic reticulum stress signaling in cancer","volume":"85","author":"Sch\u00f6nthal","year":"2013","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.M113.527754_bib14","doi-asserted-by":"crossref","first-page":"a013185","DOI":"10.1101\/cshperspect.a013185","article-title":"The mammalian endoplasmic reticulum-associated degradation system","volume":"5","author":"Olzmann","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"10.1074\/jbc.M113.527754_bib15","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/jcp.21364","article-title":"SEL1L and HRD1 are involved in the degradation of unassembled secretory Ig-\u03bc chains","volume":"215","author":"Cattaneo","year":"2008","journal-title":"J. Cell Physiol"},{"key":"10.1074\/jbc.M113.527754_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ncb1689","article-title":"OS-9 and GRP94 deliver mutant \u03b11-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD","volume":"10","author":"Christianson","year":"2008","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.M113.527754_bib17","doi-asserted-by":"crossref","first-page":"13694","DOI":"10.1074\/jbc.M109.085340","article-title":"Deficiency of suppressor enhancer Lin12 1 like (SEL1L) in mice leads to systemic endoplasmic reticulum stress and embryonic lethality","volume":"285","author":"Francisco","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.527754_bib18","doi-asserted-by":"crossref","first-page":"18708","DOI":"10.1074\/jbc.M110.210740","article-title":"mSEL-1L (suppressor\/enhancer Lin12-like) protein levels influence murine neural stem cell self-renewal and lineage commitment","volume":"286","author":"Cardano","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.527754_bib19","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1038\/sj.onc.1206665","article-title":"SEL1L expression in pancreatic adenocarcinoma parallels SMAD4 expression and delays tumor growth in vitro\nin vivo","volume":"22","author":"Cattaneo","year":"2003","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.527754_bib20","article-title":"Putative tumor suppressor gene SEL1L was down-regulated by aberrantly up-regulated hsa-mir-155 in human pancreatic ductal adenocarcinoma","author":"Liu","year":"2013","journal-title":"Mol. Carcinog"},{"key":"10.1074\/jbc.M113.527754_bib21","first-page":"567","article-title":"SEL1L expression decreases breast tumor cell aggressiveness in vivo\nin vitro","volume":"62","author":"Orlandi","year":"2002","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M113.527754_bib22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2559.2005.02274.x","article-title":"SEL1L expression in prostatic intraepithelial neoplasia and adenocarcinoma. An immunohistochemical study","volume":"48","author":"Barberis","year":"2006","journal-title":"Histopathology"},{"key":"10.1074\/jbc.M113.527754_bib23","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1158\/0008-5472.CAN-05-3055","article-title":"Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M113.527754_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2407-7-64","article-title":"Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process","volume":"7","author":"Chandran","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1074\/jbc.M113.527754_bib25","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1158\/1078-0432.CCR-04-0075","article-title":"SEL1L and squamous cell carcinoma of the esophagus","volume":"10","author":"Granelli","year":"2004","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.M113.527754_bib26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10620-011-2026-y","article-title":"SEL1L, an UPR response protein, a potential marker of colonic cell transformation","volume":"57","author":"Ashktorab","year":"2012","journal-title":"Dig. Dis. Sci"},{"key":"10.1074\/jbc.M113.527754_bib27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.humpath.2005.12.012","article-title":"SEL1L expression in non-small cell lung cancer","volume":"37","author":"Ferrero","year":"2006","journal-title":"Hum. Pathol"},{"key":"10.1074\/jbc.M113.527754_bib28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.stem.2009.03.014","article-title":"Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens","volume":"4","author":"Pollard","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1074\/jbc.M113.527754_bib29","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.1074\/jbc.M807111200","article-title":"Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors","volume":"284","author":"Griffero","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.527754_bib30","doi-asserted-by":"crossref","first-page":"e57462","DOI":"10.1371\/journal.pone.0057462","article-title":"Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines","volume":"8","author":"Baronchelli","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M113.527754_bib31","series-title":"WHO Classification of Tumors of the Central Nervous Systems","author":"Louis","year":"2007"},{"key":"10.1074\/jbc.M113.527754_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/172460080201700205","article-title":"Production of a monoclonal antibody directed against the recombinant SEL1L protein","volume":"17","author":"Orlandi","year":"2002","journal-title":"Int. J. Biol. Markers"},{"key":"10.1074\/jbc.M113.527754_bib33","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis. A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.527754_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/genetics\/143.1.237","article-title":"The Caenorhabditis elegans Sel-1 gene, a negative regulator of Lin-12 and Glp-1, encodes a predicted extracellular protein","volume":"143","author":"Grant","year":"1996","journal-title":"Genetics"},{"key":"10.1074\/jbc.M113.527754_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-213X-10-19","article-title":"SEL1L deficiency impairs growth and differentiation of pancreatic epithelial cells","volume":"10","author":"Li","year":"2010","journal-title":"BMC Dev. Biol"},{"key":"10.1074\/jbc.M113.527754_bib36","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1200\/JCO.2008.19.0694","article-title":"Phase II trial of vorinostat in recurrent glioblastoma multiforme. A north central cancer treatment group study","volume":"27","author":"Galanis","year":"2009","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/jbc.M113.527754_bib37","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group","volume":"271","author":"Bowden","year":"1994","journal-title":"JAMA"},{"key":"10.1074\/jbc.M113.527754_bib38","first-page":"1","article-title":"Advances in the management of glioblastoma. The role of temozolomide and MGMT testing","volume":"5","author":"Thomas","year":"2013","journal-title":"Clin. Pharmacol"},{"key":"10.1074\/jbc.M113.527754_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11060-012-0871-y","article-title":"Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms","volume":"109","author":"Chen","year":"2012","journal-title":"J. Neurooncol"},{"key":"10.1074\/jbc.M113.527754_bib40","first-page":"4338","article-title":"Histone deacetylase inhibitor, 2-propylpentanoic acid, increases the chemosensitivity and radiosensitivity of human glioma cell lines in vitro","volume":"125","author":"Shao","year":"2012","journal-title":"Chin. Med. J"},{"key":"10.1074\/jbc.M113.527754_bib41","doi-asserted-by":"crossref","first-page":"987495","DOI":"10.1155\/2012\/987495","article-title":"Valproic acid down-regulates the expression of MGMT and sensitizes temozolomide-resistant Glioma Cells","volume":"2012","author":"Ryu","year":"2012","journal-title":"J. Biomed Biotechnol"},{"key":"10.1074\/jbc.M113.527754_bib42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2176\/nmc.52.186","article-title":"Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain","volume":"52","author":"Osuka","year":"2012","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"10.1074\/jbc.M113.527754_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcp.20574","article-title":"SEL1L a multifaceted protein playing a role in tumor progression","volume":"208","author":"Biunno","year":"2006","journal-title":"J. Cell Physiol"},{"key":"10.1074\/jbc.M113.527754_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/stem.254","article-title":"NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts","volume":"28","author":"Fan","year":"2010","journal-title":"Stem Cells"},{"key":"10.1074\/jbc.M113.527754_bib45","doi-asserted-by":"crossref","first-page":"e11885","DOI":"10.1371\/journal.pone.0011885","article-title":"sel-11 and cdc-42, two negative modulators of LIN-12\/Notch activity in C. elegans","volume":"5","author":"Choi","year":"2010","journal-title":"PloS ONE"},{"key":"10.1074\/jbc.M113.527754_bib46","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.surg.2008.08.027","article-title":"Histone deacetylase inhibitors up-regulate Notch-1 and inhibit growth in pheochromocytoma cells","volume":"144","author":"Adler","year":"2008","journal-title":"Surgery"},{"key":"10.1074\/jbc.M113.527754_bib47","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells","volume":"107","author":"Obeng","year":"2006","journal-title":"Blood"},{"key":"10.1074\/jbc.M113.527754_bib48","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI44855","article-title":"Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells","volume":"121","author":"Siegelin","year":"2011","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M113.527754_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10014-010-0011-3","article-title":"Glioma-initiating cells and molecular pathology. Implications for therapy","volume":"28","author":"Natsume","year":"2011","journal-title":"Brain Tumor Pathol"},{"key":"10.1074\/jbc.M113.527754_bib50","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1349-7006.2011.01943.x","article-title":"Essential role of the Hedgehog signaling pathway in human glioma-initiating cells","volume":"102","author":"Takezaki","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1074\/jbc.M113.527754_bib51","first-page":"85","article-title":"Valproic acid inhibits human hepatocellular cancer cells growth in vitro\nin vivo","volume":"9","author":"Machado","year":"2011","journal-title":"J. Exp. Ther. Oncol"},{"key":"10.1074\/jbc.M113.527754_bib52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bjc.6602309","article-title":"Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells","volume":"92","author":"Stockhausen","year":"2005","journal-title":"Br. J. Cancer"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925819748030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925819748030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.527754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T20:41:53Z","timestamp":1641242513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925819748030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0021925819748030"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.527754","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}